Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

OBJECTIVE: We sought to establish the performance of cell-bound complement activation products (CB-CAPs) as a diagnostic tool to distinguish primary fibromyalgia (FM) from systemic lupus erythematosus (SLE). METHODS: A total of 75 SLE and 75 primary FM adult subjects who fulfilled appropriate classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Daniel J, Silverman, Stuart L, Conklin, John, Barken, Derren, Dervieux, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746498/
https://www.ncbi.nlm.nih.gov/pubmed/26870391
http://dx.doi.org/10.1136/lupus-2015-000127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746498/
https://www.ncbi.nlm.nih.gov/pubmed/26870391
http://dx.doi.org/10.1136/lupus-2015-000127

Ejemplares similares